The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Osteoporosis in Patients With Schizophrenia
Abstract
OBJECTIVE: Osteoporosis is regularly mentioned as a possible consequence of treatment with prolactin-increasing antipsychotic medications, but little is known about the prevalence and the degree of loss of bone mineral density in patients suffering from schizophrenia. The authors' goals were to investigate the association between schizophrenia and a decrease in bone mineral density and to get more insight into potential underlying pathophysiological mechanisms. METHOD: In a cross-sectional study, the authors used dual x-ray absorptiometry to determine bone mineral density of 75 inpatients and outpatients suffering from schizophrenia. All patients had been treated with antipsychotics for at least 1 year, and only patients between the ages of 19 and 50 were studied to exclude patients with age-related idiopathic osteoporosis. RESULTS: In men but not women with schizophrenia, bone mineral density was significantly lower than normal in the lumbar region. A comparison of loss of bone mineral density in male and female patients showed significant differences between the sexes. Bone mineral density showed a negative correlation with negative symptoms and Positive and Negative Syndrome Scale total score and a positive correlation with 25-hydroxy-vitamin D3 levels and body mass index in male patients. In female patients, a positive correlation between body mass index and bone mineral density was found. Exposure to prolactin-increasing antipsychotics was not related to bone mineral density. CONCLUSIONS: The male patients with schizophrenia in this study suffered from low bone density. This finding as well as other reports lend support to directing more attention to bone metabolism in patients with schizophrenia, although there is no universally accepted screening policy to identify individuals at high risk for osteoporosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oral health status is a frequently disregarded health issue among SMI patients (498), with low rates of dental examination within the past 12 months (569,577-579).”
From Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care (2011) · cites this paper as [498]
Citations
Cites
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
Kanis, J. А., & Kanis, J. А. (1994) · Osteoporosis International · doi:10.1007/bf01622200 · Cited by 2,532
Diagnosis of osteoporosis and assessment of fracture risk
Kanis, J. А. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08761-5 · Cited by 2,266
Webb, A. R., KLINE, L., & Holick, M. F. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-2-373 · Cited by 1,661
Environmental factors that influence the cutaneous production of vitamin D
Holick, M. F. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.3.638s · Cited by 771
The Use of Biochemical Markers of Bone Turnover in Osteoporosis
Delmas, P. D., Eastell, R., Garnero, P., Seibel, M. J., & Stepan, J. J. (2000) · Osteoporosis International · doi:10.1007/s001980070002 · Cited by 717
Garnero, P., Sornay-Rendu, E., Claustrat, B., & Delmas, P. D. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.8.1526 · Cited by 709
Empirical Assessment of the Factorial Structure of Clinical Symptoms in Schizophrenia
WHITE, L. E., Harvey, P. D., Opler, L. A., & Lindenmayer, J. (2010) · Psychopathology · doi:10.1159/000285058 · Cited by 362
Decreased Bone Density in Hyperprolactinemic Women
Klibanski, A., Neer, R. M., Beitins, I. Z., Ridgway, E. C., Zervas, N. T., & McArthur, J. W. (1980) · New England Journal of Medicine · doi:10.1056/nejm198012253032605 · Cited by 358
Glaser, D. L., & Kaplan, F. S. (1997) · Spine · doi:10.1097/00007632-199712151-00003 · Cited by 308
Flagged first, then by citations
Research works printed but not linked: 1
- Bergemann N, Auler B, Parzer P, Resch F, Mundt C, Ziegler R, Seibel M: High bone turnover but normal bone mineral density in women with schizophrenia (abstract). Bone 2001; 28:248
Cited by
Sorted by citations
Items 101–125 of 125
Antipsychotic therapies and bone health
Paschou, S. Α., Mentzelopoulos, P., & Lambrinoudaki, I. V. (2019) · Case Reports in Women s Health · doi:10.1016/j.crwh.2019.e00160 · Cited by 1
Tejón, S. G., Jato, M. I., Martin, M., Prats‐Uribe, A., Real, J., & Martín‐Lopez, L. M. (2021) · Atención Primaria · doi:10.1016/j.aprim.2021.102171 · Cited by 1
van der Leeuw, C. (2015) · doi:10.26481/dis.20150623cl · Cited by 1
Body composition and energy expenditure in men with schizophrenia
Sharpe, J.-K. (2007) · Faculty of Health · Cited by 1
Transcultural aspects of schizophrenia and old-age schizophrenia
Okasha, T. A., & Okasha, A. (2009) · Medical psychiatry · doi:10.3109/9781420080063.029 · Cited by 1
The effect of opioid dependence on conventional and novel biochemical parameters of bone metabolism
Balodimos, S., Nikolaou, K., Njau, S., Karamouzis, M., & Kovatsi, L. (2015) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2015.1068321 · Cited by 9
Wpływ flufenazyny i risperidonu na przebudowę kości u szczurów owariektomizowanych
Pytlik, M., & Fronczek-Sokół, J. (2012) · Annales Academiae Medicae Silesiensis
Population-based studies on risk of fracture in patients with neurological disorders
Pouwels, S. (2014) · Utrecht University Repository (Utrecht University)
OSTEOPORÓZA A SCHIZOFRENIE OSTEOPORÓZA A SCHIZOFRENIE
Králové, H. (2006)
Effects of severe mental illness on bone mineral density and body composition
Hervey, A. M. (2010) · Holmes Museum Of Anthropology (Wichita State University)
Subramaniam, A., Lim, S., Abdin, E., & Chong, S. A. (2016) · Journal of Mental Health · doi:10.3109/09638237.2016.1167850
“Post-menopausal decrease in oestrogen results in increased bone resorption, which is believed to be associated with a rise in the number of osteoclasts and correlated with loss of oestrogen (Hummer et al., 2005; Raisz & Rodan, 2003).”
BackgroundInfluentialSerum Vitamin D Deficiency and Risk of Schizophrenia : A Case Control Study
Ismail, R. M., Shafei, T. E., & Hussein, R. (2015) · The Egyptian Journal of Hospital Medicine · doi:10.12816/0017696
Osteoporosis in Serious Psychiatric Disorders
Yager, J. (2005) · Journal watch · doi:10.1056/jp200502240000003
Physical Activity and Quality of Life of Outpatients with Schizophrenia
Gomes, E. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/rp0s-8s94
Osteopenia by Risperidone-Induced Hyperprolactinemia: A Case Report
Milano, W., Rosa, M. D., Milano, L., Petrella, C., Ingenito, A., & Capasso, A. (2012) · Biomedical Research-tokyo
Il’ina, R. Y., Олеговна, П. О., Мухамеджанова, Л. Р., & Зиганшина, Л. Е. (2016) · Kazan medical journal · doi:10.17750/kmj2016-669
Maj, M., Ïðåçèäåíò, È., Tasman, A., & Herrman, H. (2011)
Ul'yanov, N. A. (2013) · CyberLeninK (CyberLeninka)
Diagnostic methoDs of sistemic osteoporosis in psychiatric patients
IljIna, R. Y., & MukhaMedzhanova, L. R. (2014) · The Bulletin of Contemporary Clinical Medicine · doi:10.20969/vskm.2014.7(4).22-25
Bone Disorders with Brain and Behavioral Conditions
Oleson, C. V., Ransom, T. E., & Beckley, A. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-45084-1_7
石, 丛. (2018) · Advances in Clinical Medicine · doi:10.12677/acm.2018.88128
Vitamin D Deficiency as a Risk Factor for Schizophrenia: A meta-analysis of Observational StudiesPreprint
Zhu, J.-L., Luo, W.-W., Cheng, X., Li, Y., Zhang, Q., & Wen-xing, P. (2019) · doi:10.21203/rs.2.16946/v1
“Two studies with the cutoff point of 10 [29] or 12 ng/mL [30] and seven studies had no cutoff point of VDD or lack of relevant data [8, 20, 31-35] was excluded from this meta-analysis.”
BackgroundCano-Baena, A. I., García-Ayala, L., Zubía-Martín, M., Zorrilla, E. P., & Arrillaga, A. G.-P. (2019) · Springer eBooks · doi:10.1007/978-3-030-15179-9_30
Liu, F., Wu, Y., Chen, J., Zou, T., Qin, Y., Teng, Z., Su, Y., Wu, R., & Huang, J. (2023) · Figshare · doi:10.6084/m9.figshare.23558015
Metadata
- Authors
- Hummer, M., Malik, P., Gasser, R. W., Hofer, A., Kemmler, G., Moncayo Naveda, R. C., Rettenbacher, M. A., & Fleischhacker, W. W.
- Affiliations
- Innsbruck Medical University (AT)
- Venue
- American Journal of Psychiatry
- Published
- 2005-01-01
- Volume
- 162
- Issue
- 1
- Pages
- 162-167
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2110298944
- Cited by
- 125
- References
- 30
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 4 · 2022: 2 · 2021: 4 · 2020: 1 · 2019: 4 · 2018: 6 · 2017: 6 · 2016: 6 · 2015: 7 · 2014: 7 · 2013: 6 · 2012: 7
- FWCI
- 3.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Keywords
- osteoporosis, schizophrenia, bone mineral density, antipsychotic drugs, prolactin, sex differences, body mass index, 25-hydroxyvitamin D3, bone metabolism, negative symptoms, bone loss
- MeSH terms
- Adult, Calcifediol, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Osteoporosis, Schizophrenia, Sex Factors, Antipsychotic Agents, Absorptiometry, Photon, Bone Density, Comorbidity, Body Mass Index, Sex Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
